Results 261 to 270 of about 1,177,085 (276)

Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study

Lancet, The, 2014
Eric Lawitz, Mark S Sulkowski, Zobair M Younossi   +2 more
exaly  

[EXTENDED ENDONASAL ENDOSCOPIC APPROACH IN TREATING PITUITARY ADENOMAS AND SKULL BASE TUMORS].

Harefuah
The endoscopic endonasal approach (EEA) is a rapidly growing, minimally invasive discipline applied to a broad set of skull base tumors. The introduction of the endoscopic endonasal approach for the management of lesions of the skull base has produced a paradigm shift in the way these complicated lesions are managed.
openaire   +1 more source

Targeting the Nogo Receptor to Treat Central Nervous System Injuries

Nature Reviews Drug Discovery, 2003
Stephen M Strittmatter
exaly  

From effect size into number needed to treat

Lancet, The, 1999
Toshi A Furukawa
exaly  

Tobacco Control for Clinicians Who Treat Adolescents

Ca-A Cancer Journal for Clinicians, 2003
exaly  

T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma

Cancer Cell, 2015
Ingunn M Stromnes, Thomas M Schmitt, Philip D Greenberg   +2 more
exaly  

New tricks to treat Ebola

Nature Reviews Drug Discovery, 2016
Megan Cully
exaly  

Extended-release oxybuytynin and tolterodine treat overactive bladder.

The Journal of family practice, 2004
openaire   +1 more source

Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer

Nature Reviews Drug Discovery, 2007
exaly  

Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases

Nature Reviews Drug Discovery, 2007
exaly